Empirical Methods to Calculate an Erythropoiesis-Stimulating Agent Dose Conversion Ratio in Nondialyzed Patients with Chronic Kidney Disease

BACKGROUND: Epoetin alfa and darbepoetin alfa are erythropoiesis-stimulating agents (ESAs) indicated for the treatment of anemia in chronic renal failure, including patients on dialysis and patients not on dialysis. Clinical experience demonstrates that the dose conversion ratio (DCR) between epoeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Horowitz, Jeffrey, Agarwal, Anil, Huang, Fannie, Gitlin, Mathew, Gandra, Shravanthi R., Cangialose, Charles B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437663/
https://www.ncbi.nlm.nih.gov/pubmed/19954265
http://dx.doi.org/10.18553/jmcp.2009.15.9.741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437663/
https://www.ncbi.nlm.nih.gov/pubmed/19954265
http://dx.doi.org/10.18553/jmcp.2009.15.9.741

Ejemplares similares